This study will assess the change in serum creatinine in patients with diabetes and advanced chronic kidney disease, after a fluorescein angiography. This is a before and after study that will include 35 patients from the department of ophtalmology over 6 months with a total follow-up for 3 months.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\>18 years old with type 2 or type 1 diabetes and chronic kidney disease stage 3b to 5 (eGFR\<45 mL/min/1.73 m2)
You may not be if
Patients who do not give their consent
Patients who are allergic to fluorescein
Patients who are on dialysis
Patients who had fever, vomiting, diarrhea or any dehydration 48 hours before the intervention
Patients who had a treatment modification one week before the intervention
Clareo Health | Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease
